Sedation and guided education for depression study
Part of Mental health clinical trials.
This trial tests whether combining sedation with guided education can help people with moderate to severe depression. You will not receive medication—just education while lightly sedated to see if it improves your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with moderate or severe depression
- You can read and understand English to give consent
- You are not pregnant or breastfeeding
- You do not have a substance use disorder (except maybe nicotine or caffeine)
- You do not use opioid painkillers or benzodiazepines every day
- You have never been diagnosed with psychosis, schizophrenia, or schizoaffective disorder
- Your body mass index (BMI) is 35 or lower
- You do not have moderate (untreated) or severe sleep apnea
- You do not have a stomach or esophagus condition that raises your risk of choking on stomach contents while sedated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a group education program (psychoeducation) for people with moderate to severe major depression. It’s designed to help you learn skills to manage your depression alongside medication.
This study tests how a medication called memantine affects memory and mood in people with major depression who are not currently taking antidepressants. It involves MRI scans and may help find new ways to treat depression.
This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.
This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.
This Phase 2 trial tests whether an NMDA-targeted treatment can improve symptoms of major depressive disorder (MDD). You may be able to join if your depression diagnosis and symptom score fit, and you meet several safety and study-following requirements.
This study tests a remote education program (tele-education) for people with moderate depression who recently started an antidepressant. The program helps you learn skills to manage your mood, and you can take part from home.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.